Showing results (131-140 of 157) with videos related to

Sort By:
Pageof 16
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2012
Multicenter, double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesotheliomaHedy L Kindler, Theodore G Karrison, David R Gandara, et al.
Scientific Reports|November 7, 2018
Genetic variation determines VEGF-A plasma levels in cancer patientsFederico Innocenti, Chen Jiang, Alexander B Sibley, et al.
JAMA Network Open|February 22, 2022
Associations Between Unprocessed Red Meat and Processed Meat With Risk of Recurrence and Mortality in Patients With Stage III Colon CancerErin L Van Blarigan, Fang-Shu Ou, Tiffany M Bainter, et al.
European Journal of Cancer (Oxford, England : 1990)|December 11, 2017
Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinomaMaeve A Lowery, David P Kelsen, Marinela Capanu, et al.
The Lancet. Oncology|September 13, 2020
Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 studyAurélien Marabelle, Marwan Fakih, Juanita Lopez, et al.
Journal for Immunotherapy of Cancer|February 20, 2021
Phase I study of ABBV-428, a mesothelin-CD40 bispecific, in patients with advanced solid tumorsJason J Luke, Fabrice Barlesi, Ki Chung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2025
Treatment of Pleural Mesothelioma: ASCO Guideline UpdateHedy L Kindler, Nofisat Ismaila, Lyudmila Bazhenova, et al.
Cancer Biology & Therapy|May 6, 2011
RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinomaDaniel V T Catenacci, Gustavo Cervantes, Soheil Yala, et al.
Investigational New Drugs|May 9, 2019
A phase Ib study of GSK3052230, an FGF ligand trap in combination with pemetrexed and cisplatin in patients with malignant pleural mesotheliomaEmilie M J van Brummelen, Evgeny Levchenko, Manuel Dómine, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 13, 2019
Inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapyRaffit Hassan, Betsy Morrow, Anish Thomas, et al.
Pageof 16